ustekinumab
janssen
['ustekinumab']
b0379: tuberculosis and opportunistic infections with ustekinumab (anti-p40) across all indications bottom line: incidence is very low #acg2022 
I'm a Mayo specialist in evaluation and management of patients with ulcerative colitis and Crohn's disease. Tweets are mine. Retweet doesn't mean endorsement.